Topical 0.2% Loteprednol Etabonate vs. Topical 0.1% Dexamethasone in Impending Recurrent Pterygium

Clinical trial NCT04075227 · COMPLETED

Trial details

NCT number: NCT04075227
Sponsor: Wannisa Suphachearabhan
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Recurrent Pterygium of Eye Steroid-Induced Glaucoma

Start date: 2015-10-16
Primary completion: 2019-03-02
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.